You have yet to enroll on this course. To start learning click the button below
This two module course introduces you to the current unmet need in type 1 diabetes exploring registry data that indicates glycaemic control, hypoglycaemia, and diabetic ketoacidosis all continue to be suboptimally managed in many patients. While insulin remains the mainstay of therapy for people with type 1 diabetes, it is well known to lead to weight gain, an increased risk of hypoglycemia and high variability in glycaemic profiles. In the second module, we take a more in-depth look at the clinical trials that have investigated the use of adjunct therapies in the treatment of type 1 diabetes including pramlintide, metformin, liraglutide and SGLT-2 inhibitors.
Once enrolled on a course you can access the content in any order you wish, simply browse the course using the ‘CONTENT AND YOUR PROGRESS’ section on this page.
If at any time you need help finding the next step to complete just click the green tick in the bottom right of the screen for directions.